Nursing care in patients with thrombolysis and acute myocardial infarction
Keywords:
Nursing Care, Patient-Centered Care, Myocardial Infarction, Thrombosis, NursingAbstract
The adverse effects which accompany the administering of intravenous streptokinase in patients presenting acute myocardial infarction, with less than 6 hours of evolution, were studied. 63 patients were males and 4 were females. 1.5 million units of streptokinase were used per hour, by means of an infusion pump. The main findings were minor bleeding at the sites of vein puncture or vascular incision and were controlled by local compression. Greater bleeding was seen in die digestive tract and hematuria, although none required a blood transfusion; anaphylactic and allergic reactions appeared as fever, there was no angioneurosis edema or anaphylactic shock, steroids were not needed and the fever was controlled with physical measures. There was no mortality related with this procedure.
References
National Center For Health Statistic: Monthly Vital Statistic report, Vol. 33 No. 13, Sept. 26, 1985.
National Center For Health Statistics: Detailed diagnosis and procedures for patients discharged from short-X Stay hospitals, United States,1984, data from the national Health Survey Series, Vol.13No. 86.
De Wood M-,S(JoresJ, Notske Retal: Prevalence of total coronary occlusion during the early hour transmural myocardial infarction. N Engl J Med. 303: 897. 1980.
Sanz O, Castañer A, Betriu A et al. Determinants of prognosis in survivors of myocardial infarction: A prospective clinical angiographic study. N Eng! J Med 1982306: 1065.
Chadler A, Chapman I, Erhardt L, et al. Coronary Thrombosis in myocardial infarction. AM J Cardiol 34: 8323, 1974.
Davies M, Woolf N, Robertson W. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br. Heart J. 38: 659.1976.
Horie T, Sekiguchi M, Hirosawa K. Coronacy thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br. Heart J. 40: 153,1978.
Forrester JS, Litvack F, Grundfest W et al. A perspective of coronary disease seen through the aneurism of living man. Circulation 75 (3): 505,Rer. 33. Mar.1987.
Verstraete M. Intravenous administration of thrombolytic is the only realistic therapeutic approach in evolving myocardial infarction, Eur Heart J. 1985: 6; 586.
Schroder R, Biamino G, Von Leither E et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 1983; 67: 536-548.
Martín G, Stadius M, Davis K el al. The Western Washington intravenous streptokinase trial: Effects of intravenous streptokinase on vessel patency and ventricular function. Circulation 1986; 74: 11-367.
Olson H, Butman S, Piters K, et al A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction. Am Heart J 1986; 111: 1021-1029.
Grossman W. Cardiac catheterization and angiography. Editorial LEA Febiger Philadelphia 310-315. 1980.
Thrombolytic therapy in thrombosis: A national intitules of health consensus development conference (symposium). Ann Intern med. 193: 141.1980.
Stamler J. The primery prevention of coronary heart disease. In Braunwald, E. The myocardial failure and infarction. New York. H. P. Publishing Co. J. lnc 1974. pag. 219.
TIMI Study Group: The thrombolysis in myocardial infarction trial. Phase I Findings. N. Engl J. Med.1985,312, 932.
Verstraete M, Bernard R, Bory M, el al Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction Lance! 1985 i; 842
GISSI: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986i; 397-402.
Collen D, Topol E, Tiefenbrunn A, et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: A prospective, randomized, placebo controlled trial. Circulation 1984; 70:1012.
Verstraete M, Bleifeld W, Brower R, et al. Double blind randomized trial of intravenous tissue type plasminogen activator versus placebo in acute myocardial infarction. Lancet 1985 II: 565-569.
Kennedy J, Ritchie J, Davis K, Fritz J: Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983; 309:1477-1482.
ISAM Study group: A prospective trial of intravenous streptokinase in acute myocardial infarction b: Mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986; 314: 1465-1471.
Anderson J, Marshall H, Askins J, el al. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infaction. Circulation 1984; 70: 606-608.
O´Neill W, Timmis G, Bourdillon P, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986 314; 812-818.
Sharma G, Cella G, Parisi A, et al. Thrombolysis therapy. N Eng J Med. 1982; 306:1268.
